Forging partnerships with external entities is central to GlycoNet’s strategy. By working together with research institutions, industries, government agencies, and non-for-profit organizations, we are accelerating the development and discovery of new vaccines, diagnostics, and drugs for patients. We seek partners who share complementary expertise and mutual interest in accelerating innovations to improve the life of Canadians.